发明申请
- 专利标题： Internally administered therapeutic agents for cranial nerve diseases comprising mesenchymal cells as an active ingredient
- 专利标题（中）： 包含间充质细胞作为活性成分的颅神经疾病的内用药治疗剂
-
申请号： US12149646申请日： 2008-05-06
-
公开(公告)号： US20080286246A1公开(公告)日： 2008-11-20
- 发明人: Osamu Honmou , Hirofumi Hamada
- 申请人： Osamu Honmou , Hirofumi Hamada
- 专利权人： RENOMEDIX INSTITUTE, INC.,MITSUI SUMITOMO INSURANCE CARE NETWORK COMPANY, LIMITED,ASKA PHARMACEUTICAL CO., LTD.,HITACHI LTD.
- 当前专利权人： RENOMEDIX INSTITUTE, INC.,MITSUI SUMITOMO INSURANCE CARE NETWORK COMPANY, LIMITED,ASKA PHARMACEUTICAL CO., LTD.,HITACHI LTD.
- 优先权： JP2003-185260 20030627; JP2003-432329 20031226
- 主分类号： A61K35/12
- IPC分类号： A61K35/12 ; A61P7/00
摘要：
Intravenous administration of bone marrow cells collected from rat bone marrow or peripheral blood to a rat cerebral infarction model was found to be effective in treating cerebral infarction. Human and murine bone marrow stem cells showed similar effects. Mesenchymal cells such as bone marrow cells, cord blood cells, or peripheral blood cells can be used as agents for in vivo administration against cranial nerve diseases.
公开/授权文献
信息查询
